focus -WSS

focus

author：explore 2025-09-06 05:03:04 - browse：98

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Gritstone Bio's cancer vaccine test, and more on Novartis' deal

focus

WSS

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Texas Medical Board asked to define abortion emergency exception

Johnson & Johnson sued for allegedly overpaying for workers' drugs

There’s no way to know how good AI health technologies are

entertainment

focus

hotspot

After affirmative action ruling, medical educators look to 'holistic review'

How should state employee insurance handle Wegovy?

Malaria cases in Florida and Texas: Here’s what you need to know

A protest over insulin prices is seen as a fight for life

Trump demands the U.S. pay no more for drugs than other countries … again

AI gets buy

Medicare proposal to cover medical devices draws a mixed reaction

Texas Medical Board asked to define abortion emergency exception

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Wellcome Trust names Røttingen as its new CEO

focus

Unique patient identifier: Experts argue the benefits, pitfalls

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Eight reasons why you should get an updated Covid vaccine

Akero's treatment for NASH falls short in cirrhosis study

How should state employee insurance handle Wegovy?

focus

leisure time

focus

hotspot